Gepafor®
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
Hepatoprotective efficacy of the drug Gepafora is due to the peculiarity of its structure, which ensures the mutually potentiating effect of all its constituent components - dry thistle extract and probiotic component containing microcolonies of bifidobacteria and lactobacteria, sorbed on colloidal silicon dioxide.
Thistle dry spotted extract:
- It has a stabilizing effect on the membrane of the liver cell.
- Slows down the processes of cytolysis and the penetration of toxins into the liver cells.
- Stimulates the synthesis of proteins and enzymes in hepatocytes.
- Prevents the development of cholestasis.
- Reduces the toxic load on the liver.
- It participates in the metabolism of proteins, fats and carbohydrates, providing the formation of amino acids, vitamins, organic and short-chain fatty acids, improving tissue trophism and liver function.
- Transforms exo- and endotoxins, transforming them into non-toxic compounds that are eliminated from the body.
- Restores the process of bile evacuation and prevents the formation of gallstones.
- Creates optimal conditions for the rapid recovery of intestinal normal flora and its protective functions.
Indications
The drug is used by adults of all age groups in complex therapy in the treatment of:
- Toxic liver damage (including medicinal).
- Acute viral and chronic hepatitis, including drugs, including those developed on the background of the use of anti-tuberculosis drugs, and to restore intestinal normal flora.
- Chronic hepatitis of various etiologies, including those with dysfunction of the biliary tract.
- Cirrhosis of the liver (as part of complex therapy).
- Conditions after suffering hepatitis.
- Acute viral hepatitis.
- Cirrhosis of the liver.
The drug is used for prophylactic purposes for chronic intoxication (including professional), long-term medication and alcohol intake.
Composition
active substances: | |
dry thistle extract | 0.1 g |
bifidobacterium bifidum sorbed on colloidal silicon dioxide | not less than 50 million (5 × 107) CFU |
lactobacillus fermentum sorbed on colloidal silicon dioxide | not less than 50 million (5 × 107) CFU |
excipients: lactulose - up to 0.2 g; colloidal silicon dioxide - 0.0006 g |
No customer reviews for the moment.
Dosage and Administration
For the treatment of acute viral hepatitis: 1 capsule 3 times a day, the course of treatment is 15 days.
For the treatment of other diseases: 2 capsules 3 times a day, the course of treatment is 14-30 days.
For prophylaxis: 1-2 capsules 3 times a day, a course of treatment for 14-30 days, if necessary, repeat the course in 1-3 months.
Contraindications
Individual intolerance.
Special instructions
Before use, it is recommended to consult with a specialist.
- Brand name: Gepafor®
- Active ingredient: Milk thistle extra dry, bifidobacterium bifidum, lactobacillus fermentum
- Dosage form: Capsules
- Manufacturer: Partner
- Country of Origin: Russia